ECN-31358-60208
2 vaccinations
4 coded responses
13 check-ins
4 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 079 / NJ
- Registered
- 2021-03-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-04
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-05
Registered in v-safe
-
2021-03-05
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-06
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-08
- 2021-03-09
- 2021-03-10
-
2021-03-11
Survey response — day 7, dose 1MedDRA: Cough — Feeling: GoodFree text: CoughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-18
-
2021-03-25
Survey response — day 21, single doseMedDRA: Cough, Respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Cough and congestionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-25
Report sent to call center — day 21, single doseBe unable to do your normal daily activities1 call case(s)
-
2021-04-03
Survey response — day 28, single doseMedDRA: Cough, Rhinorrhoea — Feeling: GoodFree text: Cough, runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-08
- 2021-04-15
-
2021-06-03
Survey response — 3 months, dose 1MedDRA: Arthralgia, Neuralgia, Office visit, Physiotherapy — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: SI joint and nerve pain · Healthcare visit (other): Chiropractor and physical therapyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-03
Report sent to call center — 3 months, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-08
- 2021-09-02
-
2021-11-17
Dose 2 — Pfizer-BioNTech
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-04 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-17 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 unsuccessful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 5 — day 7, dose 1
Systemic reaction (other): Cough
Release 6 — day 21, single dose
Symptoms: Cough and congestion
Release 6 — day 28, single dose
Symptoms: Cough, runny nose
Release 8 — 3 months, dose 1
Symptoms: SI joint and nerve pain
Healthcare visit (other): Chiropractor and physical therapy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| HCVO | Physiotherapy | ✓ | ✓ | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Neuralgia | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release